GLPwatch
Trials (2036)
Page 4 of 34.
- Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
- Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
- A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
- A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
- Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
- Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
- ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
- A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects
- Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
- Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- Efficacy and Safety of Tirzepatide for Weight Management
- Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
- Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
- Epicardial Cardiac Fat-CT (EPIC-CT)
- Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
- A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
- GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
- Brain Activation and Satiety in Children 2
- Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
- Genetics of the Acute Response to Oral Semaglutide
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
- Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
- Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
- A Study of LY3437943 in Participants With Type 2 Diabetes
- A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
- Tirzepatide Use in People With Obesity and Type 1 Diabetes
- A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
- A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
- GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
- Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
- The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
- In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
- A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity